Considering that the mRNA levels of DTL showed clinical relevance with the survival status of follow-up patients in the chi-square test (Table 1, bottom, p = 0.018), we next wondered whether the DTL overexpression affects the clinical prognosis of the HCC cohort. This evidence concerns the gene DTL and hepatocellular carcinoma.